2021 China New Design Dmpa Photoinitiator - Hydroxypyrazolodpyrimidine pyrazolo(3,4-d)pyrimidin-1-ol – JIN DUN

Short Description:

Product Detail

Product Tags

Feedback (2)

With a sound enterprise credit history, exceptional after-sales services and modern production facilities, we've earned an outstanding track record amongst our consumers across the whole world for Vascular Physiology, Commercial Water Softener, Tertiary Treatment Of Water, To learn more about what we can easily do in your case, make contact with us at any time. We glance forward to developing superior and long-term organization interactions along with you.

2021 China New Design Dmpa Photoinitiator - Hydroxypyrazolodpyrimidine pyrazolo(3,4-d)pyrimidin-1-ol – JIN DUN Detail:

It is clinically used in primary and secondary Hyperuricemia, especially in patients with hyperuricemia, as well as in patients with renal insufficiency, and in patients with recurrent or chronic gout, as well as in patients with Hyperuricemia. Used in patients with Gouty nephropathy to relieve symptoms and reduce the formation of renal uric acid stones; gout stones; used in uric acid kidney stones and uric acid kidney disease.

This product and its metabolites can inhibit xanthine oxidase, so that hypoxanthine and xanthine cannot be converted into uric acid, that is, the synthesis of uric acid is reduced, thereby reducing the concentration of uric acid in the blood and reducing the concentration of urate in the bones, Joints and kidneys, drugs that can inhibit the synthesis of uric acid. This product can inhibit the activity of liver drug enzymes.

(1) . Primary and secondary hyperuricemia, especially those with excessive uric acid production, are also used for hyperuricemia with renal insufficiency;

(2) . For the treatment of gout, suitable for recurrent or chronic gout. For patients with gouty nephropathy, it can relieve symptoms and reduce the formation of uric acid stones in the kidneys;

(3) . Tophi;

(4) . Used for uric acid kidney stones and (or) uric acid nephropathy.

Standard：usp42
Assay：98-102%

Exterior：White or almost white powder
Package : 25kg/bag

There is bone marrow suppression, which can cause pancytopenia, and the drug should be discontinued if necessary. Drink plenty of water during the medication, and make the urine neutral or alkaline to excrete diuretic acid. This product must be applied after the acute inflammation of gouty arthritis disappears (usually about two weeks after the onset). During medication, blood picture and liver and kidney function should be checked regularly.

Product detail pictures:

Related Product Guide:

Our solutions are broadly acknowledged and dependable by users and may meet consistently developing economic and social requires for 2021 China New Design Dmpa Photoinitiator - Hydroxypyrazolodpyrimidine pyrazolo(3,4-d)pyrimidin-1-ol – JIN DUN , The product will supply to all over the world, such as: Swiss, Slovakia, Serbia, They are sturdy modeling and promoting effectively all over the world. Never ever disappearing major functions within a quick time, it's a have to in your case of fantastic good quality. Guided by the principle of "Prudence, Efficiency, Union and Innovation. the corporation. ake an excellent efforts to expand its international trade, raise its organization. rofit and raise its export scale. We have been confident that we've been going to have a bright prospect and to be distributed all over the world in the years to come.

Antipsychotic Meds